345 related articles for article (PubMed ID: 6446389)
1. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
2. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
3. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
5. Microbiological studies on cefoperazone.
Kayser FH
Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
[No Abstract] [Full Text] [Related]
6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
Auckenthaler R; Waldvogel FA
Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
[TBL] [Abstract][Full Text] [Related]
8. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
Knothe H
Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of five cephalosporins.
Mutton KJ; Harkness JL
Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
[TBL] [Abstract][Full Text] [Related]
10. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
12. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
13. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Garcia-Rodriguez JA
Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
[No Abstract] [Full Text] [Related]
14. [Computerized analysis of activity profiles of beta-lactams].
Pitton JS; Philippin JL; Fournier P
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
[TBL] [Abstract][Full Text] [Related]
15. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
Digranes A; Bjorvatn B
NIPH Ann; 1980 Dec; 3(2):141-7. PubMed ID: 7219840
[TBL] [Abstract][Full Text] [Related]
16. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
Corser CA; Day GJ; Humble MW
N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
[TBL] [Abstract][Full Text] [Related]
17. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
Duval J; Deforges L; Bergogne-Berezin E; Chabbert YA; Courtieu AL; Cluzel R; Dabernat H; Witchitz JL
Sem Hop; 1983 Jun; 59(26):1949-52. PubMed ID: 6310784
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Lang SD; Durack DT
Clin Ther; 1980; 3(Spec Issue):112-6. PubMed ID: 6248219
[No Abstract] [Full Text] [Related]
19. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]